Angina Prevalence and Provider Evaluation of Angina Relief (APPEAR)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01705054|
Recruitment Status : Completed
First Posted : October 12, 2012
Last Update Posted : June 22, 2017
|Condition or disease|
|Stable Coronary Artery Disease CAD|
|Study Type :||Observational|
|Actual Enrollment :||1246 participants|
|Official Title:||Angina Prevalence and Provider Evaluation of Angina Relief|
|Study Start Date :||July 2013|
|Actual Primary Completion Date :||July 2015|
|Actual Study Completion Date :||July 22, 2015|
Outpatient Coronary Artery Disease Patient
CAD patients being seen in a participating cardiology office for a scheduled clinic visit who agree to take the survey.
- Seattle Angina Questionnaire [ Time Frame: One time cardiology office visit. ]Percentage of patients with frequent angina (>1 episode/week) as measured by the Seattle Angina Questionnaire (SAQ).
- Quality of Life [ Time Frame: One time cardiology office visit. ]Evaluate the impact of frequent angina on Quality of Life (as measured by the SAQ)
- Physician Perspective [ Time Frame: One time cardiology office visit. ]Identifying differences between patients' and cardiologists' assessment of angina control
- Cardiology practices angina control. [ Time Frame: One time cardiology office visit. ]Evaluate the differences in angina control between cardiology practices.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01705054
|United States, Missouri|
|Saint Luke's Hospital of Kansas City|
|Kansas City, Missouri, United States, 64111|
|Principal Investigator:||John A Spertus, MD, MPH||Saint Luke's Hospital of Kansas City|
|Principal Investigator:||Faraz Kureshi, MD||Saint Luke's Hospital of Kansas City|